Dr. BJ Mahendra kumar*1, Jagadish babu D2, Jyothi K2,
*1Professor, Department of Clinical pharmacy,
Sri Adichunchanagiri College of pharmacy, Mandya, Karnataka, India.
2Scholars, Department of Clinical pharmacy,
Sri Adichunchanagiri College of pharmacy, Karnataka,
Antibiotics are among the most widely prescribed therapeutic agents among paediatrics patients.1 As we all know, the advantage of therapy with a cephalosporin not only lies in its rather broad spectrum but also in its low toxicity and the drug can be used safely in pregnant women and children. Such therapy can reduce the duration of hospitalization if the susceptible bacterial pathogens have been almost eradicated by a parental cephalosporin and patient’s condition has been brought under control.2 Despite their widespread use in paediatrics, few antibiotics have been studied adequately to be considered safe and effective for use in children. Oral third-generation cephalosporins used commonly in paediatrics include cefixime, cefpodoxime, ceftibuten, and cefdinir.3